BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8291274)

  • 1. [Primary pulmonary hypertension].
    Winkler J
    Z Gesamte Inn Med; 1993 Nov; 48(11):555-62. PubMed ID: 8291274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of chronic cor pulmonale].
    Schauer J
    Z Gesamte Inn Med; 1993 Nov; 48(11):544-9. PubMed ID: 8291272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New etiopathogenic, diagnostic and therapeutic aspects in primary pulmonary hypertension].
    Fernández A; Guerra MF; Camino E; Puras A
    An Med Interna; 1995 Jun; 12(6):294-8. PubMed ID: 7548649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary pulmonary hypertension: new treatment options].
    Madan S; Boonstra A; Berger RM
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary pulmonary hypertension].
    Svendsen UG; Andersen CB; Aldershvile J; Handberg J; Olsen PS
    Ugeskr Laeger; 1999 Feb; 161(7):935-40. PubMed ID: 10051801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary pulmonary hypertension and its management].
    Crespo Martínez C; Morales León V; Alonso Ramos H; Alonso Ortiz B; Molero Gómez R
    Farm Hosp; 2004; 28(1):48-55. PubMed ID: 15012178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension and chronic cor pulmonale.
    Fishman AP; Palevsky HI
    Heart Dis Stroke; 1993; 2(4):335-41. PubMed ID: 8156186
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
    Hughes JD; Rubin LJ
    Medicine (Baltimore); 1986 Jan; 65(1):56-72. PubMed ID: 2867454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute circulatory failure caused by primary pulmonary hypertension or pulmonary embolism].
    Meyer G; Sanchez O
    Rev Mal Respir; 2000 Feb; 17(1):51-65. PubMed ID: 10756556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
    Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
    J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?
    Gurtner HP
    Bull Eur Physiopathol Respir; 1979; 15(5):897-923. PubMed ID: 389330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of cor pulmonale.
    Romano PM; Peterson S
    Heart Dis; 2000; 2(6):431-7. PubMed ID: 11728294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary pulmonary hypertension.
    Gaine SP; Rubin LJ
    Lancet; 1998 Aug; 352(9129):719-25. PubMed ID: 9729004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension: current aspects].
    Tello de Meneses R; Gómez Sánchez MA; Delgado Jiménez J; Gómez Pajuelo C; Sáenz de la Calzada C; Zarco Gutiérrez P
    Rev Esp Cardiol; 1996 Aug; 49(8):554-66. PubMed ID: 8756200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension and cor pulmonale caused by chronic obstructive lung disease; pathogenesis and treatment].
    Dees A; Heysteeg M; de Leeuw PW
    Ned Tijdschr Geneeskd; 1991 Jun; 135(25):1120-4. PubMed ID: 1857437
    [No Abstract]   [Full Text] [Related]  

  • 17. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary pulmonary hypertension. World Health Organization.
    Fauzi AR
    Med J Malaysia; 2000 Dec; 55(4):529-37; quiz 538. PubMed ID: 11221172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy].
    Schilling W
    Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.